(NASDAQ: SENS) Senseonics Holdings's forecast annual revenue growth rate of 37.63% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.53%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.95%.
Senseonics Holdings's revenue in 2026 is $40,711,000.On average, 9 Wall Street analysts forecast SENS's revenue for 2026 to be $2,648,594,059, with the lowest SENS revenue forecast at $2,482,594,485, and the highest SENS revenue forecast at $2,804,769,937. On average, 10 Wall Street analysts forecast SENS's revenue for 2027 to be $4,070,898,141, with the lowest SENS revenue forecast at $3,405,478,544, and the highest SENS revenue forecast at $5,565,646,760.
In 2027, SENS is forecast to generate $4,206,632,368 in revenue, with the lowest revenue forecast at $3,592,797,630 and the highest revenue forecast at $5,600,761,251.